MS
Insider
Michael Schmertzler
DirectorMichael Schmertzler (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $1.8M of PTCT (24,390 sh across 3 lots, as filed), executed Aug 26.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.2M
shares × price, as filed
Last traded
Sep 17
Filed Sep 18
Median ADV $125.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
PTCTRecent filings
PTCTSALE
PTC Therapeutics, Inc.
View filing →
$1.3M19,624 sh across 3 lots
Exec Sep 16
Filed Sep 18 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $1.3M
19,428 sh across 2 lots
Exec Sep 9
Filed Sep 11 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $1.8M
24,390 sh across 3 lots
Exec Aug 26
Filed Aug 28 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $1.8M
24,309 sh across 4 lots
Exec Aug 19
Filed Aug 21 · 5:20 PM ET